| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/03/2004 | US20040106780 Preparing antibody isolated from blood for treatment of thrombocytopenia, tetanus, rubella and viral diseases |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106777 Comprises nucleotide sequences coding extracelular matrix interacting protein for screening and identifying modulators and treatment for cancers and arteriosclerosis; tissue engineering |
| 06/03/2004 | US20040106771 Natural antibodie active against hiv virus |
| 06/03/2004 | US20040106183 Shingolipid ceramide deacylase gene |
| 06/03/2004 | US20040106180 Protein purification |
| 06/03/2004 | US20040106179 Comprises lyases enzymatic peptide for use in screening modulator for treatment and prevention of cardiovascular disorders |
| 06/03/2004 | US20040106161 Using monoclonal antibody to prevent interaction between tyrosine kinase receptor and ligand; designing treatment for tumors; immunotherapy; antitumor agents |
| 06/03/2004 | US20040106149 Novel gpcr hfrbn63 |
| 06/03/2004 | US20040106143 Monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 06/03/2004 | US20040106134 Comprises genetically engineered immunoglobulin for use in the treatment of bone disorders |
| 06/03/2004 | US20040106127 Comprises nucleotide sequences coding human adult and embryonic whole brain polypeptides; microarry for genome analysis; proteomics |
| 06/03/2004 | US20040106120 Identifying nucleotide sequence changes/polymorphism associated with abnormal cell adhesion and treating skin, asthma and chronic obstruction pulmonary disease using enzyme inhibitors |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040105872 which contains a cytosine, guanine dinucleotide sequence and stimulates (for example, has a mitogenic effect) vertebrate immune cells |
| 06/03/2004 | US20040105871 Pox viral vector plasmid construct comprising a vaccine insert that encodes at least two antigens; DNA-based vaccine can be tailored for the type of immune response that will be mobilized |
| 06/03/2004 | US20040105865 Treatment and diagnosis of prostate cancer |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105860 Modulation of endothelial cells and cell proliferation and endothelial cells |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | US20040105855 Compries immunoglobulin which binds tumor necrosis factor receptor and functions as antitumor agent in the treatment of cancer |
| 06/03/2004 | US20040105854 monoclonal or polyclonal antibodies with histidine polypeptides for immunization |
| 06/03/2004 | US20040105841 Interferons, uses and compositions related thereto |
| 06/03/2004 | US20040105816 Cancerous disease modifying antibodies |
| 06/03/2004 | US20040105815 By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodies for therapeutic and diagnostic purposes |
| 06/03/2004 | DE10254601A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use |
| 06/03/2004 | CA2847795A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2599222A1 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | CA2511680A1 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 06/03/2004 | CA2507373A1 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | CA2506890A1 Method for isolating intracellular antibodies able to neutralize protein interactions |
| 06/03/2004 | CA2506724A1 Antibodies, polypeptides and uses thereof |
| 06/03/2004 | CA2506625A1 Autocrine growth factor receptor antibodies and methods |
| 06/03/2004 | CA2506505A1 Antibodies lacking vacuolar targeting signal peptide and capable of binding j-chain |
| 06/03/2004 | CA2506331A1 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | CA2506230A1 Anti-angiogenic uses of il-6 antagonists |
| 06/03/2004 | CA2506128A1 Anti-activated ras antibodies |
| 06/03/2004 | CA2506127A1 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization |
| 06/03/2004 | CA2506124A1 Intracellular antibodies |
| 06/03/2004 | CA2505994A1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 06/03/2004 | CA2505991A1 Human monoclonal antibodies against cd25 |
| 06/03/2004 | CA2505919A1 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 06/03/2004 | CA2505898A1 Intrabodies against the oncogenic form of ras |
| 06/03/2004 | CA2505717A1 Use of multi-specific, non-covalent complexes for targeted delivery of therapeutics |
| 06/03/2004 | CA2505601A1 Complement receptor 2 targeted complement modulators |
| 06/03/2004 | CA2503708A1 Monoclonal antibodies against n-terminus probnp |
| 06/03/2004 | CA2502668A1 Fully human antibody fab fragments with human interferon-gamma neutralizing activity |
| 06/02/2004 | EP1424558A1 Reagent for assaying laminin 5 antigen in biological sample and assay method |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1423708A1 Compositions and methods for aa4rp assay |
| 06/02/2004 | EP1423704A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders |
| 06/02/2004 | EP1423701A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423520A2 Dna sequences that encode variable regions of antibodies that bind to the prion protein (prp), and prp-binding polypeptides |
| 06/02/2004 | EP1423519A2 G-protein coupled receptor and dna sequences thereof |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423510A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 06/02/2004 | EP1423432A2 Interleukin-1 beta antibodies |
| 06/02/2004 | EP1423431A2 Antibodies to vla-1 |
| 06/02/2004 | EP1423429A2 Antibodies against caspase-8, their preparation and use |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423427A2 Nogo receptor homologues and their use |
| 06/02/2004 | EP1423425A2 Receptor, the use thereof, and mouse antibodies |
| 06/02/2004 | EP1423424A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423420A2 Novel genetic products obtained from ashbya gossypii, which are associated with transcription mechanisms, rna processing and/or translation |
| 06/02/2004 | EP1423417A2 Peptides mimicking a cryptic epitope of gp41 of hiv-1 and antibodies directed against them |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423412A2 Homing peptides |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
| 06/02/2004 | EP1423135A2 Methods for inhibiting angiogenesis |
| 06/02/2004 | EP0981541B1 Psca: prostate stem cell antigen |
| 06/02/2004 | EP0948344A4 Synthetic antibiotics |
| 06/02/2004 | EP0941334B1 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 06/02/2004 | EP0807178B1 Mycobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 06/02/2004 | EP0792279B1 Antibiotic cryptdin peptides and methods of their use |
| 06/02/2004 | CN1501812A Antithrombotic agents |
| 06/02/2004 | CN1152053C Method for inducting and preparing epitope idiosyncratic monoclonal antibody using epitope polypeptide |
| 06/01/2004 | US6743908 For use in cancer diagnosis and therapy |
| 06/01/2004 | US6743898 Monoclonal antibodies that suppress B cell growth and/or differentiation |
| 06/01/2004 | US6743896 Protien for use in the treatment of infection and tumors |
| 06/01/2004 | US6743622 Homologous recombination antibody expression system for murine cells |
| 06/01/2004 | US6743617 Can be used against bacterial infections, as digestive enzyme in some mollusks which live on bacteria, anti-tumor agent |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743603 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 06/01/2004 | US6743592 Methods, systems and kits for immuno-detection of epitopes expressed on molecules |
| 06/01/2004 | US6743590 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743427 Prevention and treatment of amyloidogenic disease |
| 06/01/2004 | CA2034034C Process for the production of antibodies |
| 05/27/2004 | WO2004044584A1 Method for identifying antigen specific b cells |
| 05/27/2004 | WO2004044553A2 Lepidoptera voltage-gated calcium channels |
| 05/27/2004 | WO2004044227A2 Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/27/2004 | WO2004044220A2 Flaviviris fusion inhibitors |
| 05/27/2004 | WO2004044204A2 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 05/27/2004 | WO2004044203A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044198A1 Antibodies recognizing chondroitin sulfate b and chondroitin sulfate e |
| 05/27/2004 | WO2004044191A1 Antimicrobial activity of antibodies producing reactive oxygen species |